These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 18506105

  • 1. Endotoxin-binding affinity of sevelamer hydrochloride.
    Perianayagam MC, Jaber BL.
    Am J Nephrol; 2008; 28(5):802-7. PubMed ID: 18506105
    [Abstract] [Full Text] [Related]

  • 2. Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.
    Sun PP, Perianayagam MC, Jaber BL.
    J Ren Nutr; 2009 Sep; 19(5):432-8. PubMed ID: 19464926
    [Abstract] [Full Text] [Related]

  • 3. Novel dosage forms and regimens for sevelamer-based phosphate binders.
    Duggal A, Hanus M, Zhorov E, Dagher R, Plone MA, Goldberg J, Burke SK.
    J Ren Nutr; 2006 Jul; 16(3):248-52. PubMed ID: 16825030
    [Abstract] [Full Text] [Related]

  • 4. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
    Oka Y, Miyazaki M, Takatsu S, Kunitomo K, Uno F, Maruyama M, Matsuda H.
    Ther Apher Dial; 2007 Apr; 11(2):107-13. PubMed ID: 17381531
    [Abstract] [Full Text] [Related]

  • 5. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
    Pai AB, Shepler BM.
    Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
    [Abstract] [Full Text] [Related]

  • 6. Kinetic and thermodynamic evaluation of phosphate ions binding onto sevelamer hydrochloride.
    Elsiddig R, Hughes H, Owens E, O' Reilly NJ, O'Grady D, McLoughlin P.
    Int J Pharm; 2014 Oct 20; 474(1-2):25-32. PubMed ID: 25102115
    [Abstract] [Full Text] [Related]

  • 7. Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.
    Hauser AB, Azevedo IR, Gonçalves S, Stinghen A, Aita C, Pecoits-Filho R.
    Blood Purif; 2010 Oct 20; 30(3):153-8. PubMed ID: 20861617
    [Abstract] [Full Text] [Related]

  • 8. Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride.
    Autissier V, Damment SJ, Henderson RA.
    J Pharm Sci; 2007 Oct 20; 96(10):2818-27. PubMed ID: 17497733
    [Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 20; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Gastric pH, sevelamer hydrochloride and omeprazole.
    Capitanini A, Lupi A, Osteri F, Petrone I, Del Corso C, Straniti M, Gallieni M, Rossi A.
    Clin Nephrol; 2005 Oct 20; 64(4):320-2. PubMed ID: 16240906
    [Abstract] [Full Text] [Related]

  • 11. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
    Kimura D, Totapally BR, Raszynski A, Ramachandran C, Torbati D.
    Crit Care Med; 2008 Oct 20; 36(10):2823-7. PubMed ID: 18766096
    [Abstract] [Full Text] [Related]

  • 12. Nonphosphate-binding effects of sevelamer--are they of clinical relevance?
    Marangon N, Lindholm B, Stenvinkel P.
    Semin Dial; 2008 Oct 20; 21(5):385-9. PubMed ID: 18573137
    [Abstract] [Full Text] [Related]

  • 13. The influence of poly(allylamine hydrochloride) hydrogel crosslinking density on its thermal and phosphate binding properties.
    Elsiddig R, O'Reilly NJ, Hudson SP, Owens E, Hughes H, O'Grady D, McLoughlin P.
    Int J Pharm; 2022 Jun 10; 621():121806. PubMed ID: 35526696
    [Abstract] [Full Text] [Related]

  • 14. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism.
    Sun PP, Perianayagam MC, Jaber BL.
    Kidney Int Suppl; 2009 Dec 10; (114):S20-5. PubMed ID: 19946323
    [Abstract] [Full Text] [Related]

  • 15. Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
    Akatsuka T, Mochizuki T, Koike T.
    Ther Apher Dial; 2008 Jun 10; 12(3):216-25. PubMed ID: 18503699
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
    Sonikian M, Metaxaki P, Karatzas I, Vlassopoulos D.
    Blood Purif; 2009 Jun 10; 27(2):182-6. PubMed ID: 19141997
    [Abstract] [Full Text] [Related]

  • 18. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
    Kuwahara M, Inoshita S, Terada Y, Sasaki S.
    Ther Apher Dial; 2009 Feb 10; 13(1):42-8. PubMed ID: 19379169
    [Abstract] [Full Text] [Related]

  • 19. Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance capillary electrophoresis.
    Swearingen RA, Zhorov E, Cohen A, Sybertz T, Barry EF.
    J Pharm Biomed Anal; 2004 Jun 29; 35(4):753-60. PubMed ID: 15193719
    [Abstract] [Full Text] [Related]

  • 20. A phosphate binding assay for sevelamer hydrochloride by ion chromatography.
    Mazzeo JR, Peters RM, Hanus MR, Chen X, Norton KA.
    J Pharm Biomed Anal; 1999 May 29; 19(6):911-5. PubMed ID: 10698557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.